White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Fracture Risk Assessment in People Living with HIV Infection

Stone, Benjamin J (2019) Fracture Risk Assessment in People Living with HIV Infection. M.D. thesis, University of Sheffield.

Text (PDF)
Stone, B. (Feb 2019). Fracture Risk Assessment in People Living with HIV Infection.pdf
Available under License Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 UK: England & Wales.

Download (4Mb) | Preview


Background: People living with HIV (PLWH) are at higher risk of reduced bone mineral density (BMD) and fragility fracture compared to the general population. Possible causes include: an increased prevalence of general fracture risk factors (GFRFs) in PLWH; a direct effect of HIV; and a contributory role of antiretroviral therapy. HIV guidelines recommend FRAX® (www.sheffield.ac.uk/FRAX) for fracture risk assessment in PLWH. FRAX®, however, incorporates GFRFs but not HIV disease-specific factors. Hypotheses: 1. Both HIV disease-specific factors and GFRFs contribute to reduced BMD and fracture risk in PLWH. 2. FRAX® correlates poorly with BMD in PLWH. Methods: Phase One: The prevalence of GFRFs and fractures were recorded in PLWH. FRAX® 10-year osteoporotic fracture probabilities (FRAX® scores) were calculated. Phase Two: A subset of the Phase One cohort were recruited proportionately by race, gender and FRAX® scores (low, intermediate and high) for dual-energy X-ray absorptiometry BMD measurements, vertebral fracture risk assessment and blood and urine sampling for biochemical and immunological markers. T-cell and monocyte subsets were assessed using flow cytometry. Results: Phase One (n = 625): GFRFs were prevalent, but FRAX® scores and fragility fracture prevalence were low. Phase Two (n = 114): FRAX®-incorporated GFRFs and increased cumulative protease inhibitor exposure (but no other HIV disease-specific factor) were significant independent determinants of reduced BMD. Non-classical monocytes were also associated with reduced BMD. There was a significant negative correlation between FRAX® scores and BMD in black patients (p=0.003 for lumbar spine and total hip) and between FRAX® hip scores and total hip BMD in white patients (p=0.030). Total hip BMD differed significantly between patients with low FRAX® hip scores (0.999 ± .113 g cm-2) and high FRAX® hip scores (0.882 ± .136g cm-2) (p<0.001). Conclusions: FRAX®-incorporated GFRFs were the predominant determinants of reduced BMD. FRAX® correlated well with BMD and may be of value for fracture risk assessment in specific HIV-positive patient subgroups.

Item Type: Thesis (M.D.)
Keywords: HIV, bone health, fracture risk assessment, FRAX
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Medicine (Sheffield)
Identification Number/EthosID: uk.bl.ethos.770231
Depositing User: Dr Benjamin J Stone
Date Deposited: 25 Mar 2019 10:23
Last Modified: 25 Sep 2019 20:07
URI: http://etheses.whiterose.ac.uk/id/eprint/23270

You do not need to contact us to get a copy of this thesis. Please use the 'Download' link(s) above to get a copy.
You can contact us about this thesis. If you need to make a general enquiry, please see the Contact us page.

Actions (repository staff only: login required)